Natera (NTRA) reported $2.3B in revenue for fiscal 2025, +35.9% year on year. That ranks #1260 by revenue among 2853 SEC filers and #113 in Healthcare. It posted a net loss of −$208M for the same year. Revenue has grown 27.5% a year on average since 2014 ($159M then). The fiscal 2025 balance sheet shows $2.4B in total assets, $1.1B in cash and $283M in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $2.3B | +35.9% | FY20252025-12-31 |
| Gross profit | Not reported | — | |
| Operating incomeOperatingIncomeLoss | −$310M | −$87.6M | FY20252025-12-31 |
| Net incomeNetIncomeLoss | −$208M | −$17.7M | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $215M | +58.7% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $106M | +59.9% | FY20252025-12-31 |
| Total assetsAssets | $2.4B | +44.4% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $1.7B | +43.2% | FY20252025-12-31 |
| CashCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | $1.1B | +13.8% | FY20252025-12-31 |
| Long-term debtLongTermDebt | $283M | +0.5% | FY20232023-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $697M | −$85.1M | Open → |
| Q2 20262026-06-30 | $753M | −$67.0M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 141 of 161 companies compared | −9.0% | |
| Operating marginRank 147 of 160 companies compared | −13.4% | |
| R&D as share of revenueRank 17 of 102 companies compared | 27.1% | |
| Cash as share of revenueRank 9 of 160 companies compared | 46.7% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Natera, Inc.
- Ticker
- NTRA
- Exchange
- Nasdaq
- SIC classification
- Services-Medical Laboratories (8071)
- Fiscal year end
- 12-31
- CIK
- 0001604821
Filings
- 10-QAug 7, 2026Open filing →
- 10-QMay 8, 2026Open filing →
- 10-KFeb 27, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Royalty PharmaRPRX | $2.4B | $771M |
| Hims & Hers HealthHIMS | $2.3B | $128M |
| ExelixisEXEL | $2.3B | $783M |
| NateraNTRA | $2.3B | −$208M |
| EnovisENOV | $2.2B | −$1.2B |
| Icu MedicalICUI | $2.2B | $732,000 |
| Sarepta TherapeuticsSRPT | $2.2B | −$713M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Natera — Key figures |url=https://companiesranked.com/en/company/natera |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Natera — Key figures. CompaniesRanked. https://companiesranked.com/en/company/nateraBibTeX
@misc{companiesranked-en-company-natera-2026,
author = {{CompaniesRanked}},
title = {{Natera — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/natera}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001104659-26-020881 · February 27, 2026
{{cite web |title=Natera — Key figures — 10-K (0001104659-26-020881) |url=https://www.sec.gov/Archives/edgar/data/1604821/000110465926020881/ntra-20251231x10k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-27}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.